Clinical trials for stage 2 melanoma

Arm B. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Last Update Posted : November 18, See Contacts and Locations. Study Description. MedlinePlus related topics: Melanoma.

Drug Information available for: Nivolumab. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.

For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U.

Federal Government. Read our disclaimer for details. Estimated Study Completion Date :. Drug: Nivolumab mg nivolumab fixed dose given as minute iv infusion every 4 weeks for 12 doses over 1 year Other Name: Opdivo. Contact: Bastian Schilling, Prof.

Principal Investigator: Bastian Schilling, Prof. Contact: Julia K. Principal Investigator: Julia Tietze, Dr. Contact: Julia Welzel, Prof. Principal Investigator: Julia Welzel, Prof.

Josef-Hospital - Dermatologische Studienambulanz. Contact: Thilo Gambichler, Prof. Principal Investigator: Thilo Gambichler, Prof. Contact: Friedegund Meier, Prof. Principal Investigator: Friedegund Meier, Prof. Contact: Rudolf Herbst, Prof. Principal Investigator: Rudolf Herbst, Prof. Contact: Dirk Schadendorf, Prof. Principal Investigator: Dirk Schadendorf, Prof. Contact: Christoffer Gebhardt, Prof. Principal Investigator: Christoffer Gebhardt, Prof. Sub-Investigator: Thomas Haalck. Contact: Axel Hauschild, Prof.

Principal Investigator: Axel Hauschild, Prof. Contact: Jan C. Principal Investigator: Jan C. Contact: Jochen S. Principal Investigator: Jochen S. Contact: Lucie Heinzerling, Prof. Principal Investigator: Lucie Heinzerling, Prof. Contact: Carsten Weishaupt, Dr.

Principal Investigator: Carsten Weishaupt, Dr. Contact: Michael Fluck, Dr. Principal Investigator: Michael Fluck, Dr. Non-Discrimination Notice. All rights reserved. Skip Navigation. I Want To I Want to Find Research Faculty Enter the last name, specialty or keyword for your search below. Apply for Admission M.